Taylor Morrison Home Corporation (TMHC) Stock Competitors & Peer Comparison
See (TMHC) competitors and their performances in Stock Market.
Peer Comparison Table: Residential Construction Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| TMHC | $71.53 | +0.04% | 6.7B | 10.66 | $6.71 | N/A |
| DHI | $145.60 | -0.55% | 41.3B | 13.67 | $10.65 | +1.20% |
| LEN | $90.49 | -1.51% | 22.9B | 13.03 | $6.95 | +2.21% |
| PHM | $118.40 | +0.15% | 22.6B | 11.45 | $10.34 | +0.81% |
| LEN-B | $88.66 | -1.25% | 22.4B | 12.76 | $6.95 | +2.21% |
| NVR | $6,182.55 | +0.09% | 16.7B | 15.11 | $409.55 | N/A |
| TOL | $137.91 | -1.37% | 12.9B | 10.47 | $13.16 | +0.73% |
| IBP | $197.61 | -2.53% | 5.3B | 21.11 | $9.36 | +1.66% |
| MDC | $62.98 | +0.05% | 4.7B | 11.91 | $5.29 | +3.41% |
| MTH | $68.33 | +0.21% | 4.6B | 12.47 | $5.48 | +2.59% |
Stock Comparison
TMHC vs DHI Comparison June 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.7B. In comparison, DHI has a market cap of 41.3B. Regarding current trading prices, TMHC is priced at $71.53, while DHI trades at $145.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 10.66, whereas DHI's P/E ratio is 13.67. In terms of profitability, TMHC's ROE is +0.11%, compared to DHI's ROE of +0.13%. Regarding short-term risk, TMHC is less volatile compared to DHI. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check DHI's competition here
TMHC vs LEN Comparison June 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.7B. In comparison, LEN has a market cap of 22.9B. Regarding current trading prices, TMHC is priced at $71.53, while LEN trades at $90.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 10.66, whereas LEN's P/E ratio is 13.03. In terms of profitability, TMHC's ROE is +0.11%, compared to LEN's ROE of +0.08%. Regarding short-term risk, TMHC is less volatile compared to LEN. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check LEN's competition here
TMHC vs PHM Comparison June 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.7B. In comparison, PHM has a market cap of 22.6B. Regarding current trading prices, TMHC is priced at $71.53, while PHM trades at $118.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 10.66, whereas PHM's P/E ratio is 11.45. In terms of profitability, TMHC's ROE is +0.11%, compared to PHM's ROE of +0.16%. Regarding short-term risk, TMHC is less volatile compared to PHM. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check PHM's competition here
TMHC vs LEN-B Comparison June 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.7B. In comparison, LEN-B has a market cap of 22.4B. Regarding current trading prices, TMHC is priced at $71.53, while LEN-B trades at $88.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 10.66, whereas LEN-B's P/E ratio is 12.76. In terms of profitability, TMHC's ROE is +0.11%, compared to LEN-B's ROE of +0.08%. Regarding short-term risk, TMHC is less volatile compared to LEN-B. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check LEN-B's competition here
TMHC vs NVR Comparison June 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.7B. In comparison, NVR has a market cap of 16.7B. Regarding current trading prices, TMHC is priced at $71.53, while NVR trades at $6,182.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 10.66, whereas NVR's P/E ratio is 15.11. In terms of profitability, TMHC's ROE is +0.11%, compared to NVR's ROE of +0.33%. Regarding short-term risk, TMHC is less volatile compared to NVR. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check NVR's competition here
TMHC vs TOL Comparison June 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.7B. In comparison, TOL has a market cap of 12.9B. Regarding current trading prices, TMHC is priced at $71.53, while TOL trades at $137.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 10.66, whereas TOL's P/E ratio is 10.47. In terms of profitability, TMHC's ROE is +0.11%, compared to TOL's ROE of +0.15%. Regarding short-term risk, TMHC is less volatile compared to TOL. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check TOL's competition here
TMHC vs IBP Comparison June 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.7B. In comparison, IBP has a market cap of 5.3B. Regarding current trading prices, TMHC is priced at $71.53, while IBP trades at $197.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 10.66, whereas IBP's P/E ratio is 21.11. In terms of profitability, TMHC's ROE is +0.11%, compared to IBP's ROE of +0.37%. Regarding short-term risk, TMHC is less volatile compared to IBP. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check IBP's competition here
TMHC vs MDC Comparison June 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.7B. In comparison, MDC has a market cap of 4.7B. Regarding current trading prices, TMHC is priced at $71.53, while MDC trades at $62.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 10.66, whereas MDC's P/E ratio is 11.91. In terms of profitability, TMHC's ROE is +0.11%, compared to MDC's ROE of +0.02%. Regarding short-term risk, TMHC is more volatile compared to MDC. This indicates potentially higher risk in terms of short-term price fluctuations for TMHC.Check MDC's competition here
TMHC vs MTH Comparison June 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.7B. In comparison, MTH has a market cap of 4.6B. Regarding current trading prices, TMHC is priced at $71.53, while MTH trades at $68.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 10.66, whereas MTH's P/E ratio is 12.47. In terms of profitability, TMHC's ROE is +0.11%, compared to MTH's ROE of +0.07%. Regarding short-term risk, TMHC is less volatile compared to MTH. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check MTH's competition here
TMHC vs CVCO Comparison June 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.7B. In comparison, CVCO has a market cap of 4.2B. Regarding current trading prices, TMHC is priced at $71.53, while CVCO trades at $549.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 10.66, whereas CVCO's P/E ratio is 22.92. In terms of profitability, TMHC's ROE is +0.11%, compared to CVCO's ROE of +0.18%. Regarding short-term risk, TMHC is less volatile compared to CVCO. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check CVCO's competition here
TMHC vs SKY Comparison June 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.7B. In comparison, SKY has a market cap of 4.1B. Regarding current trading prices, TMHC is priced at $71.53, while SKY trades at $74.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 10.66, whereas SKY's P/E ratio is 20.42. In terms of profitability, TMHC's ROE is +0.11%, compared to SKY's ROE of +0.13%. Regarding short-term risk, TMHC is less volatile compared to SKY. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check SKY's competition here
TMHC vs TPH Comparison June 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.7B. In comparison, TPH has a market cap of 4B. Regarding current trading prices, TMHC is priced at $71.53, while TPH trades at $46.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 10.66, whereas TPH's P/E ratio is 22.36. In terms of profitability, TMHC's ROE is +0.11%, compared to TPH's ROE of +0.06%. Regarding short-term risk, TMHC is more volatile compared to TPH. This indicates potentially higher risk in terms of short-term price fluctuations for TMHC.Check TPH's competition here
TMHC vs MHO Comparison June 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.7B. In comparison, MHO has a market cap of 3.5B. Regarding current trading prices, TMHC is priced at $71.53, while MHO trades at $137.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 10.66, whereas MHO's P/E ratio is 10.32. In terms of profitability, TMHC's ROE is +0.11%, compared to MHO's ROE of +0.11%. Regarding short-term risk, TMHC is less volatile compared to MHO. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check MHO's competition here
TMHC vs KBH Comparison June 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.7B. In comparison, KBH has a market cap of 3.3B. Regarding current trading prices, TMHC is priced at $71.53, while KBH trades at $52.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 10.66, whereas KBH's P/E ratio is 10.04. In terms of profitability, TMHC's ROE is +0.11%, compared to KBH's ROE of +0.09%. Regarding short-term risk, TMHC is less volatile compared to KBH. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check KBH's competition here
TMHC vs HOVNP Comparison June 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.7B. In comparison, HOVNP has a market cap of 3B. Regarding current trading prices, TMHC is priced at $71.53, while HOVNP trades at $20.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 10.66, whereas HOVNP's P/E ratio is -8.33. In terms of profitability, TMHC's ROE is +0.11%, compared to HOVNP's ROE of +0.04%. Regarding short-term risk, TMHC is less volatile compared to HOVNP. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check HOVNP's competition here
TMHC vs GRBK Comparison June 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.7B. In comparison, GRBK has a market cap of 3B. Regarding current trading prices, TMHC is priced at $71.53, while GRBK trades at $68.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 10.66, whereas GRBK's P/E ratio is 10.15. In terms of profitability, TMHC's ROE is +0.11%, compared to GRBK's ROE of +0.16%. Regarding short-term risk, TMHC is less volatile compared to GRBK. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check GRBK's competition here
TMHC vs CCS Comparison June 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.7B. In comparison, CCS has a market cap of 1.6B. Regarding current trading prices, TMHC is priced at $71.53, while CCS trades at $55.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 10.66, whereas CCS's P/E ratio is 12.51. In terms of profitability, TMHC's ROE is +0.11%, compared to CCS's ROE of +0.05%. Regarding short-term risk, TMHC is less volatile compared to CCS. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check CCS's competition here
TMHC vs DFH Comparison June 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.7B. In comparison, DFH has a market cap of 1.4B. Regarding current trading prices, TMHC is priced at $71.53, while DFH trades at $14.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 10.66, whereas DFH's P/E ratio is 8.53. In terms of profitability, TMHC's ROE is +0.11%, compared to DFH's ROE of +0.11%. Regarding short-term risk, TMHC is less volatile compared to DFH. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check DFH's competition here
TMHC vs LGIH Comparison June 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.7B. In comparison, LGIH has a market cap of 1.2B. Regarding current trading prices, TMHC is priced at $71.53, while LGIH trades at $50.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 10.66, whereas LGIH's P/E ratio is 16.56. In terms of profitability, TMHC's ROE is +0.11%, compared to LGIH's ROE of +0.03%. Regarding short-term risk, TMHC is less volatile compared to LGIH. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check LGIH's competition here
TMHC vs GRBK-PA Comparison June 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.7B. In comparison, GRBK-PA has a market cap of 980.2M. Regarding current trading prices, TMHC is priced at $71.53, while GRBK-PA trades at $22.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 10.66, whereas GRBK-PA's P/E ratio is 5.11. In terms of profitability, TMHC's ROE is +0.11%, compared to GRBK-PA's ROE of +0.16%. Regarding short-term risk, TMHC is less volatile compared to GRBK-PA. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check GRBK-PA's competition here
TMHC vs BZH Comparison June 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.7B. In comparison, BZH has a market cap of 709.3M. Regarding current trading prices, TMHC is priced at $71.53, while BZH trades at $25.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 10.66, whereas BZH's P/E ratio is -144.17. In terms of profitability, TMHC's ROE is +0.11%, compared to BZH's ROE of -0.00%. Regarding short-term risk, TMHC is less volatile compared to BZH. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check BZH's competition here
TMHC vs LEGH Comparison June 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.7B. In comparison, LEGH has a market cap of 566.7M. Regarding current trading prices, TMHC is priced at $71.53, while LEGH trades at $23.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 10.66, whereas LEGH's P/E ratio is 13.46. In terms of profitability, TMHC's ROE is +0.11%, compared to LEGH's ROE of +0.08%. Regarding short-term risk, TMHC is less volatile compared to LEGH. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check LEGH's competition here
TMHC vs HOV Comparison June 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.7B. In comparison, HOV has a market cap of 563M. Regarding current trading prices, TMHC is priced at $71.53, while HOV trades at $109.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 10.66, whereas HOV's P/E ratio is 30.26. In terms of profitability, TMHC's ROE is +0.11%, compared to HOV's ROE of +0.04%. Regarding short-term risk, TMHC is less volatile compared to HOV. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check HOV's competition here
TMHC vs SIC Comparison June 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.7B. In comparison, SIC has a market cap of 376M. Regarding current trading prices, TMHC is priced at $71.53, while SIC trades at $14.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 10.66, whereas SIC's P/E ratio is 7.11. In terms of profitability, TMHC's ROE is +0.11%, compared to SIC's ROE of -0.06%. Regarding short-term risk, TMHC is more volatile compared to SIC. This indicates potentially higher risk in terms of short-term price fluctuations for TMHC.Check SIC's competition here
TMHC vs UHG Comparison June 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.7B. In comparison, UHG has a market cap of 71.8M. Regarding current trading prices, TMHC is priced at $71.53, while UHG trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 10.66, whereas UHG's P/E ratio is -4.36. In terms of profitability, TMHC's ROE is +0.11%, compared to UHG's ROE of -0.23%. Regarding short-term risk, TMHC is less volatile compared to UHG. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check UHG's competition here
TMHC vs SPHL Comparison June 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.7B. In comparison, SPHL has a market cap of 8.8M. Regarding current trading prices, TMHC is priced at $71.53, while SPHL trades at $5.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 10.66, whereas SPHL's P/E ratio is -33.44. In terms of profitability, TMHC's ROE is +0.11%, compared to SPHL's ROE of -0.37%. Regarding short-term risk, TMHC is less volatile compared to SPHL. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check SPHL's competition here
TMHC vs NWHM Comparison June 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.7B. In comparison, NWHM has a market cap of 0. Regarding current trading prices, TMHC is priced at $71.53, while NWHM trades at $8.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 10.66, whereas NWHM's P/E ratio is N/A. In terms of profitability, TMHC's ROE is +0.11%, compared to NWHM's ROE of -0.15%. Regarding short-term risk, TMHC is more volatile compared to NWHM. This indicates potentially higher risk in terms of short-term price fluctuations for TMHC.Check NWHM's competition here